I would very much like to engage your services and would be very keen to hear your thoughts on my Dad’s case. I guess also we would like to understand what is happening to Dad in terms of emerging from an induced coma.Does Dad have critical care ...
SCA1 is estimated to represent 5.6% of autosomal dominant SCA ataxias.3 In addition to cerebellar symptoms found with olivoponto- cerebellar atrophy, SCA2 is associated with marked loss or slowing of saccadic eye movements, dementia, and other pe- ripheral neuropathy. Patients with SCA2 can ...
SCA1 is estimated to represent 5.6% of autosomal dominant SCA ataxias.3 In addition to cerebellar symptoms found with olivoponto- cerebellar atrophy, SCA2 is associated with marked loss or slowing of saccadic eye movements, dementia, and other pe- ripheral neuropathy. Patients with SCA2 can ...
showed that reduction of LZD dosage to ≤600 mg/day reduced adverse events such as myelosuppression and gastrointestinal disorders but not neuropathy, maintaining the success rate of the treatment [51]. However, how much LZD can be reduced while maintaining efficacy when adverse events occur is ...